📰 Beate Kampmann News
Page 4 - Beate Kampmann News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beate Kampmann. Real-time updates on events, politics, business and more.
July 3, 2023
Experts in vaccination from Germany, France and Spain, invited by the Bamberg Foundation, met in Berlin to discuss the key strategic priorities that will...
April 18, 2023
Vaccinating women in pregnancy can protect women and their infants from infectious diseases. This intervention is increasingly recognised as a safe and effective way to reduce infant morbidity and mortality.
April 12, 2023
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study has now investigated the efficacy of an initial vaccine candidate.
April 10, 2023
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study involving Charité –
April 10, 2023
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants.
April 8, 2023
FRIDAY, April 7, 2023 (HealthDay News) -- Receipt of bivalent respiratory syncytial virus prefusion F protein-based (RSVpreF) vaccine during pregnancy is safe and effective for preventing RSV illness in infants,
April 7, 2023
Respiratory Syncytial Virus (RSV) is a global pathogen that can cause severe respiratory tract illness. RSV infections can be especially dangerous for newborns and infants in general. A large-scale international vaccination study involving Charité – Universitätsmedizin Berlin and the London School of Hygiene and Tropical Medicine has now investigated the efficacy of an initial vaccine candidate. Participants were given the vaccine during pregnancy. As the researchers describe in The New Engl...
April 7, 2023
Pneumonia: Trial of vaccine to prevent RSV led by Wits vaccinologist Shabir Madhi has shown 82% efficacy.
April 7, 2023
FRIDAY, April 7, 2023 (HealthDay News) -- Receipt of bivalent respiratory syncytial virus prefusion F protein-based (RSVpreF) vaccine during pregnancy is safe and effective for preventing RSV illness in infants,
April 6, 2023
RSV vaccine given to pregnant women can reduce the risk of severe lower respiratory tract infections in newborns by 82%.